| Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer S Nagaraj, K Gupta, V Pisarev, L Kinarsky, S Sherman, L Kang, ... Nature medicine 13 (7), 828-835, 2007 | 1386 | 2007 |
| Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice T Lu, R Ramakrishnan, S Altiok, JI Youn, P Cheng, E Celis, V Pisarev, ... The Journal of clinical investigation 121 (10), 4015-4029, 2011 | 417 | 2011 |
| Nitrated α–synuclein immunity accelerates degeneration of nigral dopaminergic neurons EJ Benner, R Banerjee, AD Reynolds, S Sherman, VM Pisarev, ... PloS one 3 (1), e1376, 2008 | 403 | 2008 |
| Full-length dominant-negative survivin for cancer immunotherapy V Pisarev, B Yu, R Salup, S Sherman, DC Altieri, DI Gabrilovich Clinical Cancer Research 9 (17), 6523-6533, 2003 | 146 | 2003 |
| Tumor escape from immune response: mechanisms and targets of activity D Gabrilovich, V Pisarev Current drug targets 4 (7), 525-536, 2003 | 115 | 2003 |
| Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets P Parajuli, RL Mosley, V Pisarev, J Chavez, A Ulrich, M Varney, RK Singh, ... Experimental hematology 29 (10), 1185-1193, 2001 | 101 | 2001 |
| Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes T Ninkovic, L Kinarsky, K Engelmann, V Pisarev, S Sherman, OJ Finn, ... Molecular immunology 47 (1), 131-140, 2009 | 78 | 2009 |
| The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells ZZ Gaymalov, Z Yang, VM Pisarev, VY Alakhov, AV Kabanov Biomaterials 30 (6), 1232-1245, 2009 | 62 | 2009 |
| Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor … SN Robinson, VM Pisarev, JM Chavez, RK Singh, JE Talmadge Stem Cells 21 (4), 417-427, 2003 | 62 | 2003 |
| Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors S Nagaraj, V Pisarev, L Kinarsky, S Sherman, C Muro-Cacho, DC Altieri, ... Journal of Immunotherapy 30 (2), 169-179, 2007 | 61 | 2007 |
| Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response P Parajuli, V Pisarev, J Sublet, A Steffel, M Varney, R Singh, D LaFace, ... Cancer research 61 (22), 8227-8234, 2001 | 52 | 2001 |
| Udp‐glucose dehydrogenase as a novel field‐specific candidate biomarker of prostate cancer D Huang, GP Casale, J Tian, SM Lele, VM Pisarev, MA Simpson, ... International journal of cancer 126 (2), 315-327, 2010 | 48 | 2010 |
| Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity H Sang, VM Pisarev, C Munger, S Robinson, J Chavez, L Hatcher, ... Vaccine 21 (21-22), 3019-3029, 2003 | 48 | 2003 |
| Intracellular metabolism and action of acyclic nucleoside phosphonates on DNA replication VM Pisarev, SH Lee, MC Connelly, A Fridland Molecular pharmacology 52 (1), 63-68, 1997 | 48 | 1997 |
| Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses S von Mensdorff-Pouilly, L Kinarsky, K Engelmann, SE Baldus, ... Glycobiology 15 (8), 735-746, 2005 | 41 | 2005 |
| T cells recognize PD (N/T) R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1 VM Pisarev, L Kinarsky, T Caffrey, FG Hanisch, S Sanderson, ... International immunopharmacology 5 (2), 315-330, 2005 | 36 | 2005 |
| Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combination S Robinson, RL Mosley, P Parajuli, V Pisarev, J Sublet, A Ulrich, ... Journal of Hematotherapy & Stem Cell Research 9 (5), 711-720, 2000 | 33 | 2000 |
| Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine VM Pisarev, P Parajuli, RL Mosley, J Sublet, L Kelsey, PS Sarin, ... International journal of immunopharmacology 22 (11), 865-876, 2000 | 28 | 2000 |
| Changes of KEAP1/NRF2 and IKB/NF‐κB Expression Levels Induced by Cell‐Free DNA in Different Cell Types SV Kostyuk, LN Porokhovnik, ES Ershova, EM Malinovskaya, ... Oxidative Medicine and Cellular Longevity 2018 (1), 1052413, 2018 | 26 | 2018 |
| Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses H Sang, VM Pisarev, J Chavez, S Robinson, Y Guo, L Hatcher, C Munger, ... Cancer gene therapy 12 (4), 427-437, 2005 | 24 | 2005 |
James TalmadgeU of Nebraska Med Ctr在 immpharm.com 的电子邮件经过验证
